• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OGDEN MANUFACTURING PLANT OPTIFLUX 180NR DIALYZER FINISHED ASSMBLY DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OGDEN MANUFACTURING PLANT OPTIFLUX 180NR DIALYZER FINISHED ASSMBLY DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM Back to Search Results
Model Number OPTIFLUX 180NR DIALYZER FINISHED ASSMBLY
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Reaction (2414)
Event Date 09/06/2018
Event Type  Injury  
Manufacturer Narrative
The plant investigation is in process. A supplemental mdr will be submitted upon completion of this activity.  .
 
Event Description
A user facility clinical manager reported a patient who broke out in hives for an unspecified number of hemodialysis treatments occurring after (b)(6) 2018 while using fresenius optiflux dialyzers. The clinic manager confirmed the patient had been administered 12. 5mg of benadryl intravenously, and remained on the machine to complete treatment, after which their symptoms resolved. The clinic manager advised the patient had not missed any of their scheduled hemodialysis treatments due to the issue. Due diligence attempts were exhausted, but additional patient and device information was not provided.
 
Manufacturer Narrative
Additional information: event description updated. Brand name updated. Medical device -model # and catalog # updated.
 
Event Description
Updated event description: a user facility clinical manager reported a patient who broke out in hives for an unspecified number of hemodialysis treatments occurring after (b)(6) 2018 and before (b)(6) 2018 while using fresenius optiflux 180nr dialyzers. The clinic manager confirmed the patient had been administered 12. 5mg of benadryl intravenously prior to treatment, and remained on the machine to complete treatment, after which their symptoms resolved. The clinic manager advised the patient had not missed any of their scheduled hemodialysis treatments due to the issue.
 
Manufacturer Narrative
The reported complaint was not confirmed as the complaint device was not returned for manufacturer evaluation. A production records review was performed on the reported lot. An investigation of the device history records (dhr) was conducted by the manufacturer. There were two approved temporary deviation notices (dns) reported on the lot which were unrelated to the complaint event. There was no indication of product nonacceptance, deviation, non-conformance, rework, labeling or process control failure during the manufacturing process which could be associated with the reported event. The lot met all release criteria. A definitive conclusion regarding the complaint incident cannot be reached without physical examination of the actual device. Therefore, the complaint is not confirmed.
 
Manufacturer Narrative
The plant investigation is in process. A supplemental mdr will be submitted upon completion of this activity.   clinical investigation: the hemodialysis patient had a medical history of end stage renal disease (esrd). Based on the available information, there is a likely causal association between the fresenius optiflux dialyzer and the patient¿s allergic reaction (characterized by hives during the hd treatment). Although rare, hypersensitivity or anaphylactoid reactions to optiflux dialyzers are a known risk during hemodialysis. There is no evidence of an optiflux dialyzer product deficiency or malfunction reported for this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameOPTIFLUX 180NR DIALYZER FINISHED ASSMBLY
Type of DeviceDIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM
Manufacturer (Section D)
OGDEN MANUFACTURING PLANT
475 west 13th street
ogden UT 84404
MDR Report Key8055621
MDR Text Key126683252
Report Number1713747-2018-00446
Device Sequence Number1
Product Code KDI
Combination Product (y/n)N
PMA/PMN Number
K002761
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 03/27/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/09/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator
Device Model NumberOPTIFLUX 180NR DIALYZER FINISHED ASSMBLY
Device Catalogue Number0500318N
Was Device Available for Evaluation? No
Was the Report Sent to FDA?
Device Age MO
Event Location No Information
Date Manufacturer Received03/26/2019
Is This a Reprocessed and Reused Single-Use Device? No

Patient Treatment Data
Date Received: 11/09/2018 Patient Sequence Number: 1
Treatment
FRESENIUS BLOODLINES; FRESENIUS DIALYSIS MACHINE; FRESENIUS BLOODLINES; FRESENIUS DIALYSIS MACHINE
-
-